pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,022 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: filing×type: adcom×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT02514564: The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

Sponsor: Instituto Nacional de Cardiologia de Laranjeiras. Phase: . Conditions: Cardiovascular Diseases

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05431699: Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Human Papilloma Virus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07485699: Soy Processing and Food Allergy

Sponsor: University of Zurich. Phase: NA. Conditions: Soy Allergy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07389499: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Sponsor: Grit Biotechnology. Phase: EARLY_PHASE1. Conditions: IgA Nephropathy (IgAN), Membranous Nephropathy, ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN), Refractory Podocytopathy, Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03831932: Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07036198: CPNF Intervention Development and Testing

Sponsor: University of Washington. Phase: NA. Conditions: Alcohol Use

full page →ctgov ↗
›COMPLETEDphase readoutNCT07751198: Therapeutic Effects of Oat-based Cereal on Fetomaternal Outcomes Among Hypocalcemic Antenatal Women

Sponsor: University of Lahore Hospital (ULH). Phase: NA. Conditions: Hypocalcemia, Pregnancy Complications Affecting Fetus (Diagnosis)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05946798: Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Sponsor: Anna Stanhewicz, PhD. Phase: EARLY_PHASE1. Conditions: Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function

full page →ctgov ↗
›COMPLETEDphase readoutNCT07699263: Effect of an Occlusal Splint in Swimming Performance

Sponsor: Universidad Europea de Valencia. Phase: NA. Conditions: the Aim of This Study Was to Evaluate the Effect of a Custom Occlusal Splint on Swimming Performance, Stroke Efficiency, and Heart Rate in Master Swimmers, Athletic Performance and the Impact on Performance Factors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06934863: Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience

Sponsor: Catholic University of the Sacred Heart. Phase: . Conditions: Oral Lichen Planus, Oral Carcinoma, Oral Carcinoma in Situ

full page →ctgov ↗
›COMPLETEDphase readoutNCT06908863: Correlations Between Fine Manual Motor Skills and Speech Articulation

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Correlations Between Cerebral Motor Control During a Manual Task and During an Articulatory Task

full page →ctgov ↗
›COMPLETEDphase readoutNCT06267963: A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults

Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07655193: Improving Decision-Making for Missing Upper Front Teeth

Sponsor: King's College London. Phase: . Conditions: Hypodontia, Decision Making ,Shared, Decision Aid

full page →ctgov ↗
›COMPLETEDphase readoutNCT02917993: An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07561021: High-technology TeleRehabilitation for the Treatment of the FRAgile Patient

Sponsor: University of Salerno. Phase: NA. Conditions: Heart Failure, Prefrail Elderly, Frail Elderly Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06084221: Fatal Overdose Review Teams - Research to Enhance Surveillance Systems

Sponsor: Indiana University. Phase: NA. Conditions: Substance-Related Disorders, Opioid-Related Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07639814: My Wellness Begins With the Steps!

Sponsor: Pontificia Universidad Catolica de Chile. Phase: . Conditions: Physical Activity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06332014: Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Sponsor: Amgen. Phase: PHASE4. Conditions: Osteoporosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07535021: The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Colorectal Cancer, Coping, Cognitive, Psychological Well-Being

full page →ctgov ↗
›COMPLETEDphase readoutNCT05405114: Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Sponsor: Novo Nordisk A/S. Phase: PHASE2. Conditions: Sickle Cell Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02100904: Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

Sponsor: University of California, San Francisco. Phase: . Conditions: Uterine Fibroids

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07152184: Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE2. Conditions: Patient With Schizophrenia Spectrum Disorder, NLM Classification WM 203, Psychology:Schizophrenic Psychology, Schizophrenia Spectrum and Other Psychotic Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890884: A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Lymphoma, Large B-Cell, Diffuse

full page →ctgov ↗
›TERMINATEDphase readoutNCT02551484: Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Healing After Amputation of the Leg

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: A Stabilized Definitive Prosthesis (Procedure 1), Definitive Prosthesis With a Contact Socket (Procedure 1), Patients in the Initial Phase (Temporary Prosthesis, Rehabilitation) Following Unilateral Post- Transtibial Amputation (Procedure 2)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07496333: The Effect of Virtual Reality Distraction on Pain During Colonoscopy

Sponsor: Max Healthcare Insititute Limited. Phase: NA. Conditions: Valid MeSH Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT07742033: Active Cycle Of Breathing Technique And Pursed Lip Breathing in Moderate to Severe COPD Patients

Sponsor: University of Lahore. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329933: Dexamethasone, Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy

Sponsor: Benha University. Phase: NA. Conditions: GIT Function, Cholecystectomy, Laparoscopic, Dexamethasone, Dexmedetomidine, I-FEED Score

full page →ctgov ↗
›RECRUITINGphase readoutNCT07487649: Treatment Response in Patients With Medication-Overuse Headache

Sponsor: Sultan 1. Murat State Hospital. Phase: . Conditions: Medication-overuse Headache, Treatment, Headache, Greater Occipital Nerve Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT05849038: Inflammation and Depression in People With HIV

Sponsor: Emory University. Phase: PHASE2. Conditions: HIV, Depression, Anhedonia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04793958: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Sponsor: Mirati Therapeutics Inc.. Phase: PHASE3. Conditions: Advanced Colorectal Cancer, Metastatic Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07276958: A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT00471848: Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia

Sponsor: European Society for Blood and Marrow Transplantation. Phase: PHASE2. Conditions: Aplastic Anemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07401355: Improved Management of Soft Tissue Sarcomas Patients With an Optimized and Innovative Sorting Technology for Circulating Tumor Cells

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Diagnosis of Soft Tissue Sarcoma (STS)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03127826: Validation of the STarT Back Screening Tool in the Military

Sponsor: Brooke Army Medical Center. Phase: NA. Conditions: Low Back Pain, Lumbago, Radiculopathy, Intervertebral Disc Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06480526: Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Sponsor: St. Jude Children's Research Hospital. Phase: . Conditions: High-risk Neuroblastoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05354778: HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Sponsor: Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo. Phase: NA. Conditions: Healthcare-Associated Pneumonia, Ventilator Associated Pneumonia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04599478: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Sponsor: Yale University. Phase: PHASE2. Conditions: Loss-of-control Eating, Obesity/Overweight

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04257578: Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

Sponsor: University of Washington. Phase: PHASE1. Conditions: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06989385: CORALINE - Correlation Between Physiological and Clinical Variables and Failure of Non-Invasive Respiratory Support in Patients With Acute Respiratory Failure

Sponsor: University of Modena and Reggio Emilia. Phase: . Conditions: Acute Respiratory Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07211243: Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers

Sponsor: Lohmann & Rauscher. Phase: NA. Conditions: Venous Leg Ulcer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07600515: Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors

Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: . Conditions: Locally Advanced Cervical Cancer, Prognostic Biomarker

full page →ctgov ↗
›RECRUITINGphase readoutNCT07376915: Acute Effect of Graded Motor Imagery on Ankle Rehabilitation: A Pilot Study

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Ankle Instability, Healthy Controls

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00951535: A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Sponsor: Cancer Trials Ireland. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07129135: Effect of Methylene Blue Bladder Instillation on Urinary Tract Injuries During Cesarean Hysterectomy for Placenta Accreta Spectrum

Sponsor: Usama Ahmed Elsaeed Salem, MD. Phase: NA. Conditions: Placenta Accreta Spectrum, Abnormal Placentation, Cesarean Hysterectomy, Urinary Tract Injury, Bladder Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07680608: Neurophysiological and Sleep-Related Effects of a Cosmetic Shampoo and Conditioner in Adults With Scalp Discomfort

Sponsor: Zentrela Inc.. Phase: . Conditions: Dandruff

full page →ctgov ↗
›COMPLETEDphase readoutNCT06184308: Improving Outcomes in PICS With Home-Based Program of Rehabilitation and Health Coaching

Sponsor: Mayo Clinic. Phase: NA. Conditions: Post-Intensive Care Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07450508: Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma

Sponsor: Cairo University. Phase: PHASE3. Conditions: Classical Hodgkin Lymphoma Relapsed

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07405008: Laser Acupuncture on Carpal Tunnel Syndrome .

Sponsor: Cairo University. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS) in Breast Cancer Patients

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01396408: A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Advanced Rare Tumours

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07142525: Hybrid Osteoplasty Versus Osteotomy in Rhinoplasty

Sponsor: University of Sulaimani. Phase: NA. Conditions: Rhinoplasty Techniques

full page →ctgov ↗
← prev
page 134 of 141
next →